Company

CATALYST PHARMACEUTICALS, INC. (CPRX)

Standardized SEC financial data for CATALYST PHARMACEUTICALS, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001369568 · NASDAQ · Pharmaceutical Preparations.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$119.1M	$140.8M	$214.2M	$398.2M	$491.7M	$589.0M
Cost of revenue	$17.0M	$21.9M	$34.4M	$52.0M	$68.8M	$87.3M
Gross profit	$102.0M	$118.9M	$179.8M	$346.2M	$422.9M	$501.7M
R&D expense	$16.5M	$16.9M	$19.8M	$93.2M	$12.6M	$12.7M
SG&A expense	$44.2M	$49.6M	$57.1M	$133.7M	$177.7M	$193.8M
Operating income	$41.3M	$52.4M	$101.8M	$86.8M	$195.1M	$257.8M
Interest expense	—	—	$0	$705K	$1.4M	$466K
Pretax income	$41.9M	$52.7M	$104.7M	$94.5M	$216.3M	$283.5M
Income tax	$33.1M	$13.2M	$21.6M	$23.1M	$52.4M	$69.2M
Net income	$75.0M	$39.5M	$83.1M	$71.4M	$163.9M	$214.3M
EPS (diluted)	$0.71	$0.37	$0.75	$0.63	$1.31	$1.68

Standardized from CATALYST PHARMACEUTICALS, INC.'s SEC filings — per-share figures split-adjusted. Full history via the API.

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$130.2M	$171.4M	$298.4M	$137.6M	$517.6M	$709.2M
Inventory	$4.7M	$7.9M	$6.8M	$15.6M	$19.5M	$37.2M
Total current assets	$159.2M	$210.1M	$320.8M	$219.3M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$45.0M	$60.4M	$116.0M	$143.6M	$239.8M	$208.7M
Capital expenditures	$11K	$1.0M	$29K	$231K	$556K	$58K
Free cash flow	$45.0M	$59.4M	$116.0M	$143.4M

Get CPRX data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CPRX/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CPRX/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View CPRX filings on SEC EDGAR →